PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy

INTRODUCTION: The prognostic value of PLA2R antibody (Ab) test in clinical practice remains unclear. We aimed to evaluate its ability in predicting hard outcomes in primary membranous nephropathy (PMN) after adjustments to conventional markers of disease activity. METHODS: A total of 222 patients di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragy, Omar, Bate, Sebastian, Bukhari, Samar, Hiremath, Mrityunjay, Samani, Syazril, Khwaja, Arif, Rao, Anirudh, Kanigicherla, Durga Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403689/
https://www.ncbi.nlm.nih.gov/pubmed/37547510
http://dx.doi.org/10.1016/j.ekir.2023.05.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403689/
https://www.ncbi.nlm.nih.gov/pubmed/37547510
http://dx.doi.org/10.1016/j.ekir.2023.05.019

Ejemplares similares